Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Lee, Kyung Hee ^a   Kim, Sang Woon ^a   Kim, Jae Ryong ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COMPLEMENTARY DNA; DICHLORODIHYDROFLUORESCEIN DIACETATE; FREE RADICAL; GENE PRODUCT; HYDROGEN PEROXIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; RECOMBINANT SCATTER FACTOR; SCAVENGER; UROKINASE; OXIDIZING AGENT; RAC1 PROTEIN, HUMAN; SCATTER FACTOR;

ARTICLE; CANCER CELL; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLUORESCENCE; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR GROWTH; WESTERN BLOTTING; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; STOMACH TUMOR; TUMOR CELL CULTURE;

BLOTTING, WESTERN; HEPATOCYTE GROWTH FACTOR; HUMANS; HYDROGEN PEROXIDE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; OXIDANTS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RAC1 GTP-BINDING PROTEIN; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 67650751774     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-73     Document Type: Article

References (41)

1. Antioxidant defences. B Halliwell JMC Gutteridge, Free radicals in biology and medicine New York, NY: Oxford University Press 1999
2. Superoxide dismutase in the human colorectal canter sequence. AML Janssen CB Bosman L Kruidenier G Griffioen CBHV Lamers JHJM Van Krieken CJH Van de Velde HW Verspaget, Journal of Cancer Research and Clinical Oncology 1999 125 327 335 10.1007/s004320050282
3. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. DP Bottaro JS Rubin DL Faletto AM Chan TE Kmiecik GF Vande Woude SA Aaronson, Science 1991 251 802 804 10.1126/science.1846706 1846706 (Pubitemid 21926175)
4. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase-and AKT-dependent pathways. DC Bowers S Fan KA Walter R abounader JA Williams EM Rosen J Laterra, Cancer Res 2000 60 4277 4283 10945642 (Pubitemid 30636617)
5. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. MF Di Renzo M Olivero A Giacomini H Porte E Chastre L Mirossay B Nordinger S Bretti S Bottardi S Giordano M Plebano C Gespach PM Comoglio, Clin Cancer Res. 1995 1 2 147 154 9815967
6. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity prostate cancer cells. C Restuccia A Angeluccl GL Gravlna I Villanova A Teti A Albini M Bologna, Int J Cancer 2000 85 407 15 10.1002/(SICI)1097-0215(20000201)85:3<407::AID-IJC18>3.0.CO;2-8 10652434
7. Invasion-Metastasis by Hepatocyte Growth Factor/c-Met Signaling Concomitant with Induction of Urokinase plasminogen Activator in Human Pancreatic Cancer: Role as Therapeutic Target. KH Lee MS Hyun JY Kim, Cancer Research Treatment 2003 35 207 12
8. New insights into the control of MAP kinase pathways. J English G Pearson J Wilsbacher J Swantek M Karandikar S Xu MH Cobb, Exp Cell Res 1999 253 255 70 10.1006/excr.1999.4687 10579927
9. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. C Widmann S Gibson MB Harpe GL Johnson, Physiol Rev 1999 79 143 80 9922370
10. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines. A Gupta SF Rosenberger GT Bowden, Carcinogenesis 1999 20 2063 2073 10.1093/carcin/20.11.2063 10545407
11. Oxidants in receptor tyrosine kinase signal transduction pathways. M Aslan T Azben, Antioxid Redox Signal. 2003 5 6 781 788 10.1089/ 152308603770380089 14588151 (Pubitemid 37462061)
12. The redox regulation of LMW-PMP during cell proliferation or growth inhibition. P Chiarugi, IUBMB Life 2001 52 55 59 10.1080/15216540252774775 11795594 (Pubitemid 33769670)
13. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. J Boonstra JA Post, Gene 2004 337 1 13 10.1016/j.gene.2004.04.032 15276197
14. The actin cytoskeleton: A key regulator of apoptosis and ageing? Nature Reviews. CW Gourlay KR Ayscough, Molecular Cell Biology 2005 6 583 589 16072039 (Pubitemid 40943049)
15. Reactive oxygen species-induced molecular damage and its application in pathology. Winter S Toyokumi, Pathology International 1999 49 91 102 10.1046/j.1440-1827.1999.00829.x 10355961
16. Rac lb and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. DC Radisky DD Levy LE Littlepage HH Liu CM Nelson JE Fata D Leake EL Godden DG Albertson MA Nieto Z Werb MJ Bissell, Nature 2005 436 123 127 10.1038/nature03688 16001073
17. Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. AF Chambers AC Groom IC MacDonald, Cancer 2002 2 563 572 12154349 (Pubitemid 37328923)
18. Tumor microenvironment: What can ffusions teach us? J Kassis J Klominek EC Kohn, Diagnostic Cytopathology 2005 33 316 319 10.1002/dc.20280 16240401
19. Mitochondrial redox control of matrix metalloproteinases. KK Melson JA Melendez, Free Radical Biology & Medicine 2004 37 768 784 10.1016/j.freeradbiomed.2004.06.008 15304253
20. Inhibition of the Rac1 GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis in vivo. SS Ozaki Deshpande P Angkow J Bellan CJ Lowenstein MC Dinauer PJ Goldschmidt Clermont K lrani, FASEB J 2000 14 418 429 10657998 (Pubitemid 30086079)
21. Phagocyte NADPH oxidase p67-phox possesses a novel carboxyl terminal binding site for the GTPases Rac 2 and Cdc42. SL Faris LA Rinckel J Huang YR Hong ME Kleinberg, Biochem Biophys Res Commun 1998 247 271 276 10.1006/bbrc.1998.8775 9642115
22. Shear-induced tyrosine phosphorylation in endothelial cells requires Rac1-dependent production of ROS. LH Yeh YJ Park RJ Hansalia IS Ahmed SS Deshpande PJ Goldschmidt Clemont K Irani BR Alevriadou, AM J Physiol 1999 276 C838 C847 10199814
23. Reactive oxygen and NF-kappa B in VEGF-induced migration of human vascular smooth muscle cells. Z Wang MR Castresana WH Newman, Biochem Biophys Res Commun 2001 285 669 674 10.1006/bbrc.2001.5232 11453645
24. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. K Kosai K Matsumoto H Funakoshi T Nakamura, Hepatology 1999 30 151 159 10.1002/hep.510300102 10385651
25. Inhibitions of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated anti-apoptotic signaling: role of PI3-K and Akt kinase upon rac1. M Ozaki S Haga HG Zhang K lrani S Suzuki, Cell Death and Differentiation 2003 10 508 515 10.1038/sj.cdd.4401172
26. Potentiation of invasive activity of hepatoma cells by reactive oxygen species is mediated by autocrine/paracrine loop of hepatocyte growth factor. Y Miura Y Kozuki K Yagasaki, Biochem Biophys Res Commun 2003 305 160 165 10.1016/S0006-291X(03)00725-3 12732211
27. Overexpression of urokinase receptor in breast cancer cells result in increased tumor invasion, growth and metastasis. RH Xing SA Rabbani, Int J Cancer 1996 67 423 9 10.1002/(SICI)1097-0215(19960729)67:3<423::AID- IJC18>3.0.CO;2-8 8707419
28. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. C Duggan T Maguire E McDermott N O'Higgins JJ Fennelly MJ Duffy, Int J Cancer 1995 61 597 600 10.1002/ijc.2910610502 7768629
29. Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets. JL Yang DG Seetoo Y Wang M Ranson CR Bemey JM Ham PJ Russell PJ Crowe, Int J Cancer 2000 20 431 9 10.1002/1097-0215(20000920)89:5<431::AID-IJC6>3.0.CO;2-V
30. Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer. EF Solomayer IJ Kiel D Wallwlener S Bode G Meyberg M Sillem CH Gollan MD Kramer U Krainick G Baster, Br J Cancer 1997 76 812 8 9310251
31. Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods. C Bouchetm F Spyratos K Hacène L Furcos V Bécette J Oglobine, Br J Cancer 1998 77 9 1495 501 9652768
32. Oxidative stress induces urokinase-type plasminogen activator in RC-K8 human malignant lymphoma cells and H69 human small cell lung carcinoma cells. T Miyazono K Niiya T Kiguchi N Sakuragawa M Harada A Watanabe, Fibrinolysis Proteolysis 2000 14 366 73 10.1054/fipr.2000.0095
33. Helicobacter pylori stimulates urokinase plasminogen activator receptor expression and cell invasiveness through reactive oxygen species and NF-kB signaling in human gastric carcinoma cells. MH Kim HS Yoo MY Kim HJ Jang MK Baek HR Kim KK Kim BA Shin BW Ahn YD Jung, Int J Mol Med 2007 19 4 689 697 17334646
34. Protein kinase C isohyets as potential targets for anticancer therapy. J Hofmann, Curr Cancer Drug Targets 2004 4 125 46 10.2174/1568009043481579 15032665
35. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interactionin uPA synthesis. KH Lee MS Hyun JR Kim, Clin Exp Metastasis 2003 20 499 505 10.1023/A:1025824816021 14598883
36. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines. A Gupta SF Rosenberger GT Bowden, Carcinogenesis 1999 20 2063 2073 10.1093/carcin/20.11.2063 10545407
37. Mitogen-activated protein kinase (p38-, JNK-, ERK-) activation pattern induced by extracellular and intracellular singlet oxygen and UVA. LO Klotz C Pellieux K Briviba C Pierlot JM Aubry H Sies, Eur J Biochem 1999 260 917 922 10.1046/j.1432-1327.1999.00255.x 10103024
38. PKC controls HGF-dependent c-Met traffic, signaling and cell migration. S Kenmorgant D Zicha PJ Parker, EMBO Journal 2004 23 3721 3734 15385963 10.1038/sj.emboj.7600396
39. Reactive Oxygen Species Mediated Sustained Activation of Protein Kinase C and Extracellular Signal-Regulated Kinase for Migration of Human Hepatoma Cell HepG2. W-S Wu RK Tsai CH Chang S Wang J-R Wu Y-X Chang, Mol Cancer Res 2006 4 10 747 58 10.1158/1541-7786.MCR-06-0096 17050668
40. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines. KH Lee EY Choi MK Kim MS Hyun BI Jang TN Kim SW Kim SK Song JH kim J-R Kim, Exp Mol Med 2006 38 1 27 35 16520550 (Pubitemid 43352431)
41. MEK/ERK-mediated proliferation is negatively regulated by P38 MAP kinase in the human pancreatic cancer cell line, PANC-1. ZD Xian EA Thomas, Biochem Biophy Res Commun 2001 282 447 53 10.1006/bbrc.2001.4595